What we do Transgene Biotek Ltd is an Indian biotechnology company specializing in R&D and manufacture of diagnostic kits, vaccines, oncology treatments, and novel drug delivery technologies. |
Founded in 1,990 |
Market share Pioneer in Indian biotech with exports to Africa, Russia, China, Malaysia, and Philippines. |
Problem solved Develops diagnostics and innovative therapies addressing unmet medical needs in chronic and infectious diseases. |
Top clients or who we serve Serves pharmaceutical companies, healthcare providers, and international markets. Primarily B2B. |
Key management Dr. Koteswara Rao, Founder and Managing Director, leading the company since inception. |
Our journey and innovations Started with diagnostic kits; major milestone selling Hepatitis B vaccine tech in 1999; expanded into oral proteins, DNA vaccines, bio therapeutics. |
Where we operate India, with exports to Africa, Russia, China, Malaysia, Philippines. |
Top products or what we offer Diagnostic reagents, recombinant vaccines including Hepatitis B, Omega-3 DHA production, oral and nasal drug delivery platforms. |
Top brands - |
Raw materials needed Chemical reagents, biological materials for vaccine and diagnostic kit manufacturing. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue is largely project-based and cyclical due to R&D and regulatory approvals. |
Our industry position Among early Indian biotech firms, holding niche presence but facing growth challenges currently. |
Financial highlights FY 2024-25: Revenue Rs.1.04 crore, Net loss Rs.0.68 crore, reflecting operational challenges and legal issues. |
Geographical revenue split Mainly India with notable exports to multiple Asian and African countries. |
Order book - |
Whats driving growth R&D in novel drug delivery, vaccines, and therapeutic candidates, plus potential from NiedlFree's oral insulin project. |
Our future plans Focus on commercializing drug delivery technologies and oral insulin; succession planning for leadership transition. |
Our green promise - |
Our people and values Committed to ethical governance and employee development; facing leadership succession needs. |
Key challenges ahead Legal restrictions, financial losses, regulatory approval delays, and leadership succession risks. |
Interesting facts First Indian biotech to sell Hepatitis B vaccine technology internationally in 1999. |
Risks and strategy Managing SEBI and legal challenges with strategic focus on R&D and new drug delivery to sustain growth. |
